Welcome to O2H
 
 
Welcome to O2H
 
Heptares Therapeutics extends Multi-FTE collaboration with O2h
 
MRCT and O2h announce medicinal chemistry collaboraion. 
 
O2h at BIO2010 
Chicago, USA, 3-6May 2010 
 
O2h exhibiting at ERBI conference 2010 
Cambridge, UK, 2-3 June 2010 
 
CEO Sunil Shah speaking at SCI Drug Discovery Outsourcing Conference 2010 
London, UK, 9 June 2010 
 
O2h attending BIONJ 2010 
New Jersey, USA, 14-15 June 2010 
 
O2h attending  MassBio Signature event
Boston, USA, October 2010 
 
O2h attending ChemPharma Outsourcing 2010 
New Jersey, USA, 14-16 September 2010 
 
O2h attending BIO Europe 
Munich, Germany, 15-17 November 2010
 
 
New User Register
Vision & Future History Directors & Advisors Advantage India Partnering / Risk Share
The O2h vision to be the best performing discovery services company in the world means the client can expect that we have set ourselves the very highest standards of performance.

Following on from leadership in IT outsourcing, India has now also gained critical mass in the bio-pharma industry catalysed by implementation of the WTO IP regime and is now a global leader in chemistry. A significant base of English speaking chemists exists in India today with years of experience working for international clients.

 
The available talent pool in India is continuing to grow due to heavy investment in bio-pharma academic infrastructure and the attractiveness of working in international bio-pharma companies. Market growth is expected to remain at above 5% over next 45 years in India. The Mumbai stock market has experienced unprecedented growth alongside successive governments that have been committed to undertaking key economic reforms.
 
 
Oxygen Healthcare Ltd   23, Cambridge Science park, CB4 0EY , UK   Tel : +44 (0) 1223 437014   info@o2h.com
Sitemap